Blood News and Research

RSS

HVTN and HPTN initiate first clinical trial in response to COVID-19

The NIH-funded HIV Vaccine Trials Network (HVTN) and HIV Prevention Trials Network (HPTN) have initiated their first clinical trial in response to COVID-19.

15 May 2020

Tissue Solutions and CBSB join forces to increase COVID-19 sample availability

The UK’s leading supplier of human tissue samples is joining forces with a Cambridge Biobank to provide COVID-19 samples for scientists.

15 May 2020

Experts urge health systems to fast-track implementation of Patient Blood Management

In a new article published in print Anesthesia & Analgesia, a group of 43 leading experts have called for health systems to fast-track the implementation of Patient Blood Management.

15 May 2020

Bactiguard donates money to facilitate COVID-19 research

To contribute to the research on COVID-19, Bactiguard donates SEK 120,000 to Karolinska Institutet (KI) at Danderyd Hospital.

15 May 2020

Precision medicine can determine the best drug treatment for severe heart disease

Is personalized medicine cost-effective? University of Alabama at Birmingham researcher Nita Limdi, Pharm.D., Ph.D., and colleagues across the United States have answered that question for one medical treatment.

15 May 2020

Malaria's characteristic cycle of fever and chills is a result of parasite's own influence

Scientists from the Walter Reed Army Institute of Research joined partners at Duke University, Florida Atlantic University and Montana State University to publish a study providing clear evidence that malaria's characteristic cycle of fever and chills is a result of the parasite's own influence--not factors from the host.

15 May 2020

Researchers develop new method to study the effect of long-term oxygen deficiency

Researchers at Luleå University of Technology have developed a method to study how muscle cells in the blood vessels of the lung, permanently contract because of long-term oxygen deficiency.

15 May 2020

Antiviral agent accelerates virus clearance in cases of COVID-19

A team of researchers from have found an antiviral therapy that seems to be an effective treatment for patients with moderate coronavirus disease 2019 (COVID-19).

15 May 2020

COVID-19 and food insecurity in the U.S.

A new paper published on the preprint server medRxiv* in May 2020 reports that the measures taken to block the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) such as social distancing and lockdown are associated with widespread effects on food security in the US state of Vermont.

14 May 2020

NIH begins clinical study to evaluate hydroxychloroquine and azithromycin for COVID-19

A clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease 2019 (COVID-19).

14 May 2020

Inflammatory cells arise from local memory cells for advanced multiple sclerosis

In the brains of people that suffer from long-term multiple sclerosis (MS), inflammatory cells are not entering the brain via the bloodstream anymore.

14 May 2020

More cancer patients could benefit from CAR T-cell therapy, Moffitt study suggests

Chimeric antigen receptor T-cell therapy, or CAR T, has become a game changer for lymphoma and leukemia patients who have relapsed or become resistant to previous treatments.

14 May 2020

Using supercomputers to screen drugs for deadly heart arrhythmias

Death from sudden cardiac arrest makes headlines when it strikes athletes. But it also causes the most deaths by natural causes in the U.S. estimated at 325,000 per year.

14 May 2020

Anti-inflammatory drug may improve respiratory function in some severe COVID-19 cases

A small study in Greece found that the clinically approved anti-inflammatory drug anakinra, used to treat rheumatoid arthritis, improved respiratory function in patients with severe coronavirus disease 2019 (COVID-19).

14 May 2020

Repurposed drug normalizes body weight, reverses metabolic damage in obese mice

An off-label experiment in mice using disulfiram, which has been used to treat alcohol use disorder for more than 50 years, consistently normalized body weight and reversed metabolic damage in obese middle-aged mice of both sexes.

14 May 2020

Researchers identify a group of dysregulated genes in autism

Autism has long been associated only with behavioral and environmental factors, but the role of genetics in its development is now increasingly evident. Some 100 genes have been found to play a role in autism spectrum disorder, and another thousand are being studied to the same end.

14 May 2020

A 'window of vulnerability' for re-infection with HIV after stem cell transplantation

Some people with HIV need to undergo an allogeneic stem cell transplantation in order to treat different types of blood cancer. Most of the patient's immune cells are eliminated during these transplantations.

14 May 2020

Rotavirus infection mainly affects children under 5 years of age

A research team from the University of Valencia has carried out a study of infection and immunity markers by detecting antibodies in the blood of 7 different genotypes of the rotavirus VP8 protein, the virus that causes infectious diarrhoea, and concludes that more frequent types mainly affect the child population.

14 May 2020

Vitamin B3 has therapeutic effect in progressive muscle disease

An international team of scientists, led by University of Helsinki reported that vitamin B3, niacin, has therapeutic effect in progressive muscle disease.

14 May 2020

Variations in genome’s 'dark matter' region can make patients susceptible to inflammatory diseases

A study led by researchers at the Babraham Institute in collaboration with the Wellcome Sanger Institute has uncovered how variations in a non-protein coding 'dark matter' region of the genome could make patients susceptible to complex autoimmune and allergic diseases such as inflammatory bowel disease.

14 May 2020

Blood News and Research

HVTN and HPTN initiate first clinical trial in response to COVID-19

Tissue Solutions and CBSB join forces to increase COVID-19 sample availability

Experts urge health systems to fast-track implementation of Patient Blood Management

Bactiguard donates money to facilitate COVID-19 research

Precision medicine can determine the best drug treatment for severe heart disease

Malaria's characteristic cycle of fever and chills is a result of parasite's own influence

Researchers develop new method to study the effect of long-term oxygen deficiency

Antiviral agent accelerates virus clearance in cases of COVID-19

COVID-19 and food insecurity in the U.S.

NIH begins clinical study to evaluate hydroxychloroquine and azithromycin for COVID-19

Inflammatory cells arise from local memory cells for advanced multiple sclerosis

More cancer patients could benefit from CAR T-cell therapy, Moffitt study suggests

Using supercomputers to screen drugs for deadly heart arrhythmias

Anti-inflammatory drug may improve respiratory function in some severe COVID-19 cases

Repurposed drug normalizes body weight, reverses metabolic damage in obese mice

Researchers identify a group of dysregulated genes in autism

A 'window of vulnerability' for re-infection with HIV after stem cell transplantation

Rotavirus infection mainly affects children under 5 years of age

Vitamin B3 has therapeutic effect in progressive muscle disease

Variations in genome’s 'dark matter' region can make patients susceptible to inflammatory diseases

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News